Regulatory Background
MDA has published the 3rd edition of the guidance document on Import and/or Supply of Unregistered Medical Devices Under Special Access Exemption Application, MDA/GD/0043.
Scope of Updates
The updated guidance document further clarifies the eligibility of personnel authorised to apply for such exemptions, specifies the procedures for notification to the Authority, and details the responsibilities of applicants in the management and use of unregistered medical devices.
Special Access Pathway
The Special Access pathway is a regulatory mechanism that allows the importation and supply of unregistered medical devices to address urgent clinical needs or specialized use where no registered alternatives are available. This ensures that patients can receive essential or life-saving treatments in a safe and controlled manner. The pathway facilitates access to medical devices that are not yet registered under the Medical Device Act 2012 (Act 737), while maintaining regulatory oversight. The process flow for the Special Access can be seen in Annex A, Figure 1. The latest edition introduces several important clarifications and procedural requirements:
| Criteria for Special Access Medical Device | Further clarification on exactly which personnel are authorized to apply for these exemptions, ensuring that applications are spearheaded by qualified professionals. |
| Application Process | Specified procedures for how and when to notify MDA regarding the movement and status of these devices. |
| Applicant Responsibilities | Detailed mandates on the management and use of unregistered devices. Applicants are now under stricter oversight regarding how these devices are tracked and utilized within a clinical setting. |
| Post-Market Management | Enhanced guidelines on the responsibilities of the applicant once the device has been imported, emphasizing safety and accountability. |
Regulatory Significance
The guidance document serves as an important reference for the medical device stakeholders as it provides a clear and structured framework for the Special Access pathway in ensuring the unregistered medical devices can be accessed in urgent or exceptional situations. This process ensures that such access is carried out in a controlled and compliant manner, thereby safeguarding patient safety and maintaining regulatory oversight.
Companies seeking to supply unregistered medical devices under the Special Access pathway should review the updated requirements and ensure compliance with application, notification, and post-market obligations.
Qualtech supports manufacturers and healthcare providers in navigating Special Access applications and ensuring alignment with Medical Device Authority (MDA) requirements.
Contact us to facilitate compliant and timely access to unregistered medical devices in Malaysia.
Clarification Through Visual:
